+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmerging - Market Analysis, Trends, and Forecasts

  • ID: 4806475
  • Report
  • 102 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Csl Behring
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Otsuka Pharmaceutical
  • MORE
The Pharmerging market worldwide is projected to grow by US$780.7 Million, driven by a compounded growth of 10.9%. Pharmaceutical, one of the segments analyzed and sized in this study, displays the potential to grow at over 9.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$936.2 Million by the year 2025, Pharmaceutical will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 12.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$35.7 Million to the region's size and clout in the next 5 to 6 years. Over US$36.1 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Pharmaceutical will reach a market size of US$69.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.5% over the next couple of years and add approximately US$133.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Abbott Laboratories
  • AbbVie, Inc.
  • Alexion Pharmaceuticals, Inc.
  • Allergan PLC
  • Amgen, Inc.
  • Aspen Pharmacare Holdings Ltd.
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Baxter International, Inc.
  • Bayer AG
  • Biogen, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • CSL Behring
  • Daiichi Sankyo Co., Ltd.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Endo International PLC
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Grifols SA
  • H. Lundbeck A/S
  • Hospira, Inc.
  • Johnson & Johnson
  • Kyowa Hakko Kirin Co., Ltd.
  • Mallinckrodt Pharmaceuticals
  • Mitsubishi Tanabe Pharma Corporation
  • Mylan Pharmaceutical Pvt. Ltd.
  • Novartis AG
  • Novo Nordisk A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer, Inc.
  • Sanofi SA
  • Shire PLC
  • Stada Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma
  • Csl Behring
  • F. Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Otsuka Pharmaceutical
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Pharmerging Market to Grow Steadily, Driven by Rapid Growth of the Pharma Sector

Worldwide Pharmaceutical Market Growth Projections by Regional Group: 2018 and 2022

Breakdown of Growth Percentage and Spending in Billion USD for Pharmerging Markets by Country: 2007-2022

Global Competitor Market Shares

Pharmerging Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

Pharmaceutical Segment to Register Strong Growth

Total Spending on Medicines (in Billion USD) in Select Emerging Pharmaceutical Markets: 2023

Healthcare Market in Tier I Pharmerging Region (USD Billion) by Product: 2014-2025

Asia-Pacific Region to Retain Top Slot

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Growing Geriatric Population to Bode Well for Market Growth

Total Breakdown of People Aged Over 60 by Development Groups: 1980 to 2050

Increase in Patient Numbers to Support Market Growth

Top Therapeutic Areas by Spending (Billion USD) in Pharmerging Markets: 2018

Select Therapy Areas Spending (Billion USD) in Pharmerging Markets: 2020

Increasing Preference for Generics to Spur Market Expansion

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Pharmerging Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Pharmerging Market Share Shift across Key Geographies Worldwide: 2019 VS 2025

TABLE 3: Pharmaceutical (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 4: Pharmaceutical (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

TABLE 5: Healthcare (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 6: Healthcare (Product) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Pharmerging Market Share (in %) by Company: 2019 & 2025

TABLE 7: United States Pharmerging Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025

TABLE 8: United States Pharmerging Market Share Breakdown by Product: 2019 VS 2025

CANADA

TABLE 9: Canadian Pharmerging Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025

TABLE 10: Pharmerging Market in Canada: Percentage Share Breakdown of Sales by Product for 2019 and 2025

JAPAN

TABLE 11: Japanese Market for Pharmerging: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025

TABLE 12: Japanese Pharmerging Market Share Analysis by Product: 2019 VS 2025

CHINA

TABLE 13: Chinese Pharmerging Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025

TABLE 14: Chinese Pharmerging Market by Product: Percentage Breakdown of Sales for 2019 and 2025

EUROPE

Market Facts & Figures

European Pharmerging Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 15: European Pharmerging Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 16: European Pharmerging Market Share Shift by Region/Country: 2019 VS 2025

TABLE 17: European Pharmerging Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025

TABLE 18: European Pharmerging Market Share Breakdown by Product: 2019 VS 2025

FRANCE

TABLE 19: Pharmerging Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 20: French Pharmerging Market Share Analysis by Product: 2019 VS 2025

GERMANY

TABLE 21: Pharmerging Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025

TABLE 22: German Pharmerging Market Share Breakdown by Product: 2019 VS 2025

ITALY

TABLE 23: Italian Pharmerging Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025

TABLE 24: Italian Pharmerging Market by Product: Percentage Breakdown of Sales for 2019 and 2025

UNITED KINGDOM

TABLE 25: United Kingdom Market for Pharmerging: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025

TABLE 26: United Kingdom Pharmerging Market Share Analysis by Product: 2019 VS 2025

REST OF EUROPE

TABLE 27: Rest of Europe Pharmerging Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025

TABLE 28: Rest of Europe Pharmerging Market Share Breakdown by Product: 2019 VS 2025

ASIA-PACIFIC

TABLE 29: Pharmerging Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 30: Asia-Pacific Pharmerging Market Share Analysis by Product: 2019 VS 2025

REST OF WORLD

TABLE 31: Rest of World Pharmerging Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025

TABLE 32: Pharmerging Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2019 and 2025

IV. COMPETITION

ABBOTT LABORATORIES

ABBVIE

ALEXION PHARMACEUTICALS

ALLERGAN PLC

ASPEN PHARMACARE HOLDINGS

ASTELLAS PHARMA

ASTRAZENECA PLC

BAXTER INTERNATIONAL

BAYER AG

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

BRISTOL-MYERS SQUIBB COMPANY

CSL BEHRING

CELGENE CORPORATION

DAIICHI SANKYO

EISAI CO., LTD.

ELI LILLY AND COMPANY

ENDO INTERNATIONAL PLC

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

GRIFOLS SA

H. LUNDBECK A/S

HOSPIRA

JOHNSON & JOHNSON

MITSUBISHI TANABE PHARMA CORPORATION

MYLAN PHARMACEUTICAL PVT.

NOVARTIS AG

NOVO NORDISK A/S

OTSUKA PHARMACEUTICAL

PFIZER

STADA ARZNEIMITTEL AG

SANOFI SA

SHIRE PLC

SUN PHARMACEUTICAL INDUSTRIES

TAKEDA PHARMACEUTICAL COMPANY LIMITED

TEVA PHARMACEUTICAL INDUSTRIES

UCB SA

KYOWA HAKKO KIRIN

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Abbvie
  • Alexion Pharmaceuticals
  • Allergan Plc
  • Aspen Pharmacare Holdings
  • Astellas Pharma
  • Astrazeneca Plc
  • Baxter International
  • Bayer Ag
  • Boehringer Ingelheim International Gmbh
  • Bristol-Myers Squibb Company
  • Csl Behring
  • Celgene Corporation
  • Daiichi Sankyo
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Endo International Plc
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Grifols Sa
  • H. Lundbeck A/S
  • Hospira
  • Johnson & Johnson
  • Mitsubishi Tanabe Pharma Corporation
  • Mylan Pharmaceutical Pvt.
  • Novartis Ag
  • Novo Nordisk A/S
  • Otsuka Pharmaceutical
  • Pfizer
  • Stada Arzneimittel Ag
  • Sanofi Sa
  • Shire Plc
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries
  • Ucb Sa
  • Kyowa Hakko Kirin
Note: Product cover images may vary from those shown
Adroll
adroll